{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T14:49:29Z","timestamp":1784386169862,"version":"3.55.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T00:00:00Z","timestamp":1575504000000},"content-version":"vor","delay-in-days":4662,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1093\/annonc\/mdl431","type":"journal-article","created":{"date-parts":[[2006,12,9]],"date-time":"2006-12-09T02:05:33Z","timestamp":1165629933000},"page":"551-555","source":"Crossref","is-referenced-by-count":21,"title":["Thrombosis-related complications and mortality in cancer patients with central venous devices: an observational study on the effect of antithrombotic prophylaxis"],"prefix":"10.1016","volume":"18","author":[{"given":"D.","family":"Fagnani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Franchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Porta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Pugliese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Borgonovo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bertolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Duro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ardizzoia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Filipazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Isa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Vergani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Milani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Cimminiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3 Suppl","key":"10.1093\/annonc\/mdl431_bb0010","doi-asserted-by":"crossref","first-page":"338S","DOI":"10.1378\/chest.126.3_suppl.338S","article-title":"Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Geerts","year":"2004","journal-title":"Chest"},{"key":"10.1093\/annonc\/mdl431_bb0015","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1200\/JCO.2005.06.084","article-title":"Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo- controlled, randomized study in cancer patients","volume":"23","author":"Verso","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl431_bb0020","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/annonc\/mdj059","article-title":"Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial","volume":"17","author":"Karthaus","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdl431_bb0025","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1200\/JCO.2005.10.192","article-title":"Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer","volume":"23","author":"Couban","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl431_bb0030","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1055\/s-0038-1650254","article-title":"Upper extremity deep venous thrombosis in cancer patients with venous access devices\u2014prophylaxis with a low molecular weight heparin (Fragmin)","volume":"75","author":"Monreal","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1093\/annonc\/mdl431_bb0035","doi-asserted-by":"crossref","first-page":"423","DOI":"10.7326\/0003-4819-76-3-112-6-423","article-title":"Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial","volume":"112","author":"Bern","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1093\/annonc\/mdl431_bb0040","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1200\/JCO.2003.08.008","article-title":"Venous thromboembolism associated with long-term use of central venous catheters in cancer patients","volume":"21","author":"Verso","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl431_bb0045","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0140-6736(94)90008-6","article-title":"Double-blind randomised trial of a very low dose warfarin for prevention of thromboembolism in stage IV breast cancer","volume":"343","author":"Levine","year":"1994","journal-title":"Lancet"},{"issue":"1 Suppl","key":"10.1093\/annonc\/mdl431_bb0050","doi-asserted-by":"crossref","first-page":"132S","DOI":"10.1378\/chest.119.1_suppl.132S","article-title":"Prevention of venous thromboembolism","volume":"119","author":"Geerts","year":"2001","journal-title":"Chest"},{"key":"10.1093\/annonc\/mdl431_bb0055","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1200\/JCO.2000.18.21.3665","article-title":"Physician compliance with warfarin prophylaxis for central venous catheters in patients with solid tumors","volume":"18","author":"Carr","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl431_bb0060","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1200\/JCO.2005.03.5600","article-title":"Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer","volume":"24","author":"Lee","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl431_bb0065","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0049-3848(97)00054-6","article-title":"Central venous thrombosis: an early and frequent complication in cancer patients bearing long-term silastic catheter. A prospective study","volume":"86","author":"De Cicco","year":"1997","journal-title":"Thromb Res"},{"key":"10.1093\/annonc\/mdl431_bb0070","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1365-2141.2005.05529.x","article-title":"CATHEM Study Group. Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study","volume":"129","author":"Cortelezzi","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1093\/annonc\/mdl431_bb0075","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1046\/j.1538-7836.2003.00293.x","article-title":"Warfarin Optimal Duration Italian Trial (WODIT) Investigators. Incidence of cancer after a first episode ofidiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation","volume":"1","author":"Taliani","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1093\/annonc\/mdl431_bb0080","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJM200006293422604","article-title":"Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial","volume":"342","author":"Schulman","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdl431_bb0085","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1538-7836.2005.01735.x","article-title":"Is antithrombotic prophylaxis required in cancer patients with central venous catheters? Yes for special patient groups","volume":"4","author":"Huisman","year":"2006","journal-title":"J Thromb Haemost"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419378342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419378342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/18\/3\/551\/1350709\/mdl431.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T11:19:33Z","timestamp":1582197573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419378342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0923753419378342"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdl431","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}